Related Experiment Video
Updated: May 5, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
[A case of neonatal liver failure]
Xiao-Xiao Lu1, Yi Lu, Lin Yang
1Department of Neonatology, Children's Hospital of Fudan University/National Children's Medical Center/National Health Commission Key Laboratory of Neonatal Diseases, Shanghai 201102, China (Wang H-H, Email: huanhuan_wang@fudan.edu. cn).
This case study details a male infant with severe neonatal liver failure. Postmortem analysis suggested congenital hepatic fibrosis (CHF), highlighting the need for further research into this rare cause of infant liver disease.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Medical Genetics
Background:
- Neonatal liver failure is a critical condition requiring prompt diagnosis and management.
- Congenital hepatic fibrosis (CHF) is a rare genetic disorder typically presenting later in childhood, but its role in neonatal liver failure is under-investigated.
Observation:
- A full-term male infant presented with jaundice, abdominal distension, hepatosplenomegaly, and ascites at 28 days of age.
- The infant rapidly progressed to liver failure, coagulopathy, and thrombocytopenia despite comprehensive medical interventions.
- Whole-exome sequencing did not reveal causative genetic variants for the liver failure.
Findings:
- Postmortem liver pathology strongly suggested congenital hepatic fibrosis (CHF) as the underlying cause.
- The clinical presentation of CHF leading to neonatal liver failure is exceptionally rare.
Implications:
- This case underscores the importance of considering rare genetic conditions like CHF in the differential diagnosis of neonatal liver failure.
- Further research into the genetic basis and clinical spectrum of CHF is crucial for improving diagnostic accuracy and therapeutic strategies in affected infants.
- A multidisciplinary approach is essential for managing complex cases of neonatal liver failure.
Related Concept Videos
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Inborn Errors of Metabolism
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Encephalopathy

